Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.04 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |